InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: 4OurRetirement post# 273433

Monday, 09/26/2016 4:54:51 PM

Monday, September 26, 2016 4:54:51 PM

Post# of 345745
It will be interesting to see if shorts jump back in when PPHM jumps up only to find out they quickly cover and try to short again further upstream where the MOA of PS Targeting sits alone and far superior than all else BPs have

How many times will shorts regret shorting PPHM : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News